Open AccessPeer ReviewedPublished Monthly Since 2007 Vol. 19, Issue 12 · November 2026Media Kitinfo@guident.net

Understanding the Signals of Osseo Integration

  • Dr. Kuber SoodClinical Director

Affinity Premium Dental Clinics, New Delhi, India

Guident · Volume 7, Issue 1 (December 2013)Published December 20136 min read

INTRODUCTION

There are bioactive cytokine factors known to initiate tissue growth and bone regeneration and it is important to understand the process by which these factors interact in an implant- prosthodontic restoration system. This knowledge will help refine surgical techniques and improve implant prosthodontic results.

CYTOKINES (GROWTH FACTORS) IN INDUCING BONE FORMATION

Bone of the alveolar process and the cells of the surrounding periosteum and soft tissue respond in a very predictable way to bring about restoration of tissue integrity. In general, soft tissue changes initiated by surgery in man result primarily in a rapid repair process, usually leading to a fibrotic scar if the area is not treated by a close surgical approximation of the soft tissue. However, with bone, the osseous tissue tends to regenerate itself in the same form that existed prior to the surgical insult, that is by “regeneration” and not by “repair”.

This regeneration process is brought about primarily by the interaction of cytokines (which represent a system of proteins interacting to induce stem cells and other undifferentiated cells to participate in the repair process by forming appropriate cells such as fibroblasts, blood vessels and bone tissue itself). When bone is surgically prepared for the reception of a root form implant, the regenerative process is primarily orchestrated by these cytokines that motivate all of the cellular undeveloped non-differentiated stem cells of the adjacent bone and soft tissue to form exactly the types of cells necessary for complete osseous regeneration.

In the absence of inflammation or infection, these cytokines bring about an optimal regeneration of bone. In the case of infection or intense inflammation, the reparative process is delayed and the cellular cascade induced by the cytokines on the undifferentiated cells is disrupted.

FORMS OF CYTOKINES

There are principally two forms of cytokines which operate locally (Paracrines and Autocrines). Autocrines effect only the cells that produced them, whereas Paracrines act on adjacent cells in the same area. Those cytokines that effect distant organs of the body are called Endocrines with which we are familiar through study of the endocrine systems. Those protein cytokines that are of interest to us in producing the regeneration of a bony site for implants are the Paracrines.

PARACRINES

Paracrines are of two types: mitogenic cytokines causing merely mitosis of existing stem cells so that the stem cells increase in number, and morphogenetic cytokines which actually induce the stem cells to become osteoblasts and to form bone in the surgical site.

The stem cells which are the targets for the cytokines in directing the maturation of the immature stem cell to become osteoblasts are located in the marrow vascular spaces of the alveolar bone and in the periosteum. Thus, although stem cells are quite ubiquitous throughout the body these two sites, periosteum and the marrow vascular spaces, do contain fairly large numbers of these undifferentiated cells which can be induced to form osteoblasts and bone. These stem cells in the marrow are sometimes called prodromal cells and they express osteocalcin, osteonectin, and alkaline phosphatase. These are the markers of the immature cell which indicate that they can be targeted and programmed by the cytokines to become osteoblasts.

BONE MORPHOGENIC PROTEINS (BMPs)

Although at the present time there are many types of cytokines which are primarily mitogenic in nature, the best and most effective osteoblastic inducer of cells is through the use of Bone Morphogenetic Proteins (BMPs) . The BMPs belong to the TGF-beta family. There are many of these BMPs that have been characterized and identified at the present time. Human Recombinant Bone Morphogenetic Protein-2 (rhBMP-2) is one that has been extensively investigated in forming alveolar bone around implants and in sustaining alveolar bone while the regenerated area has been subjected to prosthetic function. The ability of the BMP to induce stem cells to regenerate large areas of the mandible following surgical resections simulating oncologic surgery . The hemi-mandibulectomy regenerations have maintained themselves over time with subsequent root form implants being stable during occlusal function .BMPs have been successfully used in locations other than large mandibular discontinuity defects.

One of the problems related to the use of cytokines to regenerate bone is that the stem cells of the marrow tend to decrease in number with age. It has been shown in some animals that the BMPs are less effective in older age groups. However it has been possible to regenerate the entire body of mandibles in old Rhesus fascicularis monkeys in excess of 20 years of age using rhBMP-2. It appears that this cytokine will be used effectively in the future in our geriatric population.

PLATELET RICH PLASMA – PLATELET DERIVED GROWTH FACTOR

At the present time it is very popular to use a plasma product by spinning down blood from the surgical patient to obtain a platelet-derived growth factor (PDGF) which can be mixed with other osseous graft materials and placed in the defects around implants to restore alveolar bone. There is a difference in the mode of action of PDGF and BMPs . The platelet-derived growth factor is therefore quite different from the action of the BMPs (especially rhBMP-2s) which are primarily morphogenetic in nature, changing the stem cells directly to osteoblasts to initiate bone formation and the regeneration cascade. While platelet-derived growth factor may assist in the healing of soft tissues of the alveolar ridge, and this type of cellular recruitment may eventually effect the overall osseous healing, it is less effective in the formation of bone than BMPs. An advantage of platelet-derived growth factor is that it can be taken from the same patient and simply given back to the patient as an autogenous graft material whereas the BMPs are derived from recombinant DNA technology and have not at this time been completely released by the Food and Drug Administration for generalized clinical use.

CARRIER SUBSTANCES FOR GROWTH FACTOR (CYTOKINES) DELIVERY

A critical part of the success of bone-inductor materials concerns the appropriate application of carrier substances to deliver the bone-inducing cytokine to the defect sites and to release the bone inductor at critical postoperative healing times. An appropriate carrier material must first have the ability to absorb, or take up on its surface through other chemicophysical mechanisms, the inductor material. Second, the material should be easily manipulated surgically and easily placed in the host osseous defect and implant site. Third, the delivery system should release the inductor material at the appropriate time for maximal bone regeneration of the defect.

The carrier materials presently available could be divided arbitrarily into those that degrade early, such as collagen, lactic acid, and tricalcium phosphate (TCP), and those that degrade over longer periods of time, such as porous hydroxylapatite (HA) and porous bone mineral.

The future use of cytokines will involve appropriate use of carrier materials around the implants.

REFERENCES

1. Wozney JM. The Bone Morphogentic Protein Family and Osteogenesis. Molecular Reproduction and Development 1992;32:160-167.

2. Boyne PJ. Animal Studies of the Application of rhBMP-2 in Maxillofacial Reconstruction. Bone 1996;19(July Supplement):83S-92S.

3. Boyne PJ, Nakamura A, Shabahang S. Evaluation of the long-term effect of function on rhBMP-2 regenerated hemimandibulectomy defects. British J of Oral Maxillofac Surg 1999;37: 344-352.

4. Boyne PJ. Application of Human Recombinant Morphogenetic Protein rhBMP-2 in the Reconstruction of Mandibulectomy and Maxillectomy Defects. In Tissue Engineering for Therapeutic Use. Ikada Y, Yamaoka Y. Elsevier Science B.V., The Hague, The Netherlands, 1998, pp. 127-137.

5. Salina S, Boyne PJ, Nakamura A, Maiorana C, Audia F. Quality of Bone Regenerated by rhBMP-2 Induction in Hemimandibulectomy Defects of Elderly Monkeys.

6. Boyne PJ. Maxillofacial Surgical Application of Bone Inductor Materials. Implant Dentistry 2001;10:2-4.

Disclaimer from Guident

The views and opinions expressed in articles published in Guident are solely those of the authors and do not necessarily reflect the views of the editors, the editorial board or the publisher, Ivory India. Guident does not endorse any product, technique or treatment described. Clinical content is intended for qualified dental and medical professionals and is not a substitute for individual clinical judgement. Guident, its editors and the publisher accept no liability for any consequence arising from the use of information published in the journal.

How to cite this article

Dr. Kuber Sood. Understanding the Signals of Osseo Integration. Guident. 2013 Dec;7(1). Available from: https://ivoryindia.in/articles/implantology/understanding-the-signals-of-osseo-integration.html

Related articles

More in Implantology

All 224 articles
Vol. 7, Issue 1 · December 2013

Maxillary Antroplasty Case Selection Protocol

For many years, open-field aluminum–nickle–cobalt magnets have been used in prosthodontics, but limited success has been achieved because of their susceptibility to corrosion by the saliva…

Dr. Manesh Lahori

Vol. 6, Issue 13 · November 2013

Imaging Modalities in Implantology

Diagnostic imaging plays an important role in evaluating the dental implant patient. Many types of radiographic imaging are recommended for treatment planning for implants. These include…

Dr. Krishna Prasad

Call for papers

Publish your clinical work in Guident

Original research, case reports and review articles are welcomed from clinicians and researchers worldwide. Every submission is assessed by the editorial board.